A rich chemokine environment strongly enhances leukocyte migration and activities.

The migration of leukocytes in immune surveillance and inflammation is largely determined by their response to chemokines. While the chemokine specificities and expression patterns of chemokine receptors are well defined, it is still a matter of debate how leukocytes integrate the messages provided by different chemokines that are concomitantly produced in physiologic or pathologic situations in vivo. We present evidence for a novel regulatory mechanism of leukocyte trafficking. Our data are consistent with a mode of action where CC-chemokine receptor 7 (CCR7) agonists and unrelated, nonagonist chemokines first form a heteromeric complex, in the presence of which the triggering of CCR7 can occur at a much lower agonist concentration. The increase is synergistic and can be evoked by many but not all chemokines. Chemokine-induced synergism might provide an amplification system in "chemokine-rich" tissues, rendering leukocytes more competent to respond to migratory cues.

[1]  D. Lo,et al.  In Vivo Inhibition of CC and CX3C Chemokine–induced Leukocyte Infiltration and Attenuation of Glomerulonephritis in Wistar-Kyoto (WKY) Rats by vMIP-II , 1998, The Journal of experimental medicine.

[2]  M. Uguccioni,et al.  I‐TAC/CXCL11 is a natural antagonist for CCR5 , 2004, Journal of leukocyte biology.

[3]  P. Loetscher,et al.  Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function , 2000, The Journal of experimental medicine.

[4]  A. Tzioufas,et al.  "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation. , 2001, Arthritis and rheumatism.

[5]  K. Matsushima,et al.  International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.

[6]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[7]  P. Proost,et al.  Synergy between proinflammatory ligands of G protein‐coupled receptors in neutrophil activation and migration , 2004, Journal of leukocyte biology.

[8]  Christoph Schaniel,et al.  Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation , 1998, European journal of immunology.

[9]  M. Baggiolini,et al.  The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC , 2001, European journal of immunology.

[10]  Ravindra Uppaluri,et al.  Cutting Edge: IFN-Producing Cells Respond to CXCR3 Ligands in the Presence of CXCL12 and Secrete Inflammatory Chemokines upon Activation1 , 2002, The Journal of Immunology.

[11]  Justine R. Smith,et al.  Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. , 2003, Blood.

[12]  T. Schwartz,et al.  A Highly Selective Cc Chemokine Receptor (Ccr)8 Antagonist Encoded by the Poxvirus Molluscum Contagiosum , 2000, The Journal of experimental medicine.

[13]  B. Sykes,et al.  Solution structure and basis for functional activity of stromal cell‐derived factor‐1; dissociation of CXCR4 activation from binding and inhibition of HIV‐1 , 1997, The EMBO journal.

[14]  E. Wolf,et al.  A Putative Chemokine Receptor, BLR1, Directs B Cell Migration to Defined Lymphoid Organs and Specific Anatomic Compartments of the Spleen , 1996, Cell.

[15]  V. Appay,et al.  Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. , 1999, The Journal of biological chemistry.

[16]  T. Springer,et al.  B Lymphocyte Chemotaxis Regulated in Association with Microanatomic Localization, Differentiation State, and B Cell Receptor Engagement , 1998, The Journal of experimental medicine.

[17]  L. Mazzucchelli,et al.  BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. , 1999, The Journal of clinical investigation.

[18]  T. Schwartz,et al.  The herpesvirus 8‐encoded chemokine vMIP‐II, but not the poxvirus‐encoded chemokine MC148, inhibits the CCR10 receptor , 2001, European journal of immunology.

[19]  B. Rollins,et al.  Chemokines and disease , 2001, Nature Immunology.

[20]  D. S. Garrett,et al.  High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. , 1994, Science.

[21]  E. Kremmer,et al.  Expression of the G-protein--coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells , 1994 .

[22]  C. Weber,et al.  Selective recruitment of Th2‐type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein‐II , 2001, European journal of immunology.

[23]  A. Imberty,et al.  Structural diversity of heparan sulfate binding domains in chemokines , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Martínez-A,et al.  The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Christopher Chin,et al.  Dimer Dissociation Is Essential for Interleukin-8 (IL-8) Binding to CXCR1 Receptor* , 2004, Journal of Biological Chemistry.

[26]  M. Baggiolini,et al.  B Cell–attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1/CXCR5 , 1998, The Journal of experimental medicine.

[27]  B. Moss,et al.  Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Proudfoot.  Chemokine receptors: multifaceted therapeutic targets , 2002, Nature Reviews Immunology.

[29]  R Bonecchi,et al.  Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. , 1998, Journal of immunology.

[30]  S. Narula,et al.  Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor. , 2001, Cytokine.

[31]  Federica Sallusto,et al.  Follicular B Helper T Cells Express Cxc Chemokine Receptor 5, Localize to B Cell Follicles, and Support Immunoglobulin Production , 2000, The Journal of experimental medicine.

[32]  Bernhard Moser,et al.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.

[33]  A. Mantovani,et al.  The chemokine system: redundancy for robust outputs. , 1999, Immunology today.

[34]  F. Sánchez‐Madrid,et al.  The chemokine SDF‐1α triggers a chemotactic response and induces cell polarization in human B lymphocytes , 1998 .

[35]  B. Dewald,et al.  Actions of the chemotactic cytokines MCP‐1, MCP‐2, MCP‐3, RANTES, MIP‐1α and MIP‐1β on human monocytes , 1995 .

[36]  A. Foussat,et al.  Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells. , 2000, Blood.

[37]  P. Allavena,et al.  The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. , 1998, Blood.

[38]  Eric J. Kunkel,et al.  CCR7 Expression and Memory T Cell Diversity in Humans1 , 2001, The Journal of Immunology.

[39]  J. Gong,et al.  An Antagonist of Monocyte Chemoattractant Protein 1 (MCP-1) Inhibits Arthritis in the MRL-lpr Mouse Model , 1997, The Journal of experimental medicine.

[40]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[41]  M. Norcross,et al.  Identification of Human Macrophage Inflammatory Proteins 1α and 1β as a Native Secreted Heterodimer* , 2001, The Journal of Biological Chemistry.

[42]  J. Cyster,et al.  Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position , 2002, Nature.

[43]  H. Nomiyama,et al.  Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7* , 1997, The Journal of Biological Chemistry.

[44]  M. Baggiolini,et al.  Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. , 2001, Blood.

[45]  J. Anderson,et al.  Chemical synthesis, purification, and folding of C-X-C and C-C chemokines. , 1997, Methods in enzymology.

[46]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[47]  C. Mackay,et al.  The role of chemokine receptors in primary, effector, and memory immune responses. , 2000, Annual review of immunology.

[48]  M. Uguccioni,et al.  Eotaxin-3/CCL26 Is a Natural Antagonist for CC Chemokine Receptors 1 and 5 , 2004, Journal of Biological Chemistry.

[49]  Y. Yamaguchi,et al.  EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. , 1998, Journal of immunology.

[50]  R. Doms,et al.  CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. , 1999 .

[51]  B. Sykes,et al.  Backbone dynamics of the human cc chemokine eotaxin: Fast motions, slow motions, and implications for receptor binding , 1999, Protein science : a publication of the Protein Society.

[52]  J. Cyster,et al.  A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  C. Boshoff,et al.  Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. , 1997, Science.

[54]  J. L. Kavanaugh,et al.  Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-γ (Mig, CXCL9) , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[55]  T. Schwartz,et al.  A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. , 1997, Science.

[56]  U. Gether.  Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.

[57]  Christophe Caux,et al.  The Inducible CXCR3 Ligands Control Plasmacytoid Dendritic Cell Responsiveness to the Constitutive Chemokine Stromal Cell–derived Factor 1 (SDF-1)/CXCL12 , 2003, The Journal of experimental medicine.

[58]  Arkadiusz Z Dudek,et al.  Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis. , 2003, Blood.

[59]  M. Uguccioni,et al.  Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes. , 2003, Blood.

[60]  R. Rabin,et al.  Human B Cells Become Highly Responsive to Macrophage-Inflammatory Protein-3α/CC Chemokine Ligand-20 After Cellular Activation Without Changes in CCR6 Expression or Ligand Binding , 2002, The Journal of Immunology.

[61]  A. Gronenborn,et al.  Three‐dimensional structures of α and β chemokines , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  M. Baggiolini,et al.  The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3* , 2001, The Journal of Biological Chemistry.

[63]  B. Nardelli,et al.  C-C Chemokine Receptor 3 Antagonism by the β-Chemokine Macrophage Inflammatory Protein 4, a Property Strongly Enhanced by an Amino-Terminal Alanine-Methionine Swap1 , 2000, The Journal of Immunology.

[64]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[65]  Jason G. Cyster,et al.  Chemokines and the Homing of Dendritic Cells to the T Cell Areas of Lymphoid Organs , 1999, The Journal of experimental medicine.

[66]  C. Mackay,et al.  Chemokines: immunology's high impact factors , 2001, Nature Immunology.

[67]  R. Hromas,et al.  Low-molecular-weight heparins inhibit CCL21-induced T cell adhesion and migration. , 2002, The Journal of pharmacology and experimental therapeutics.

[68]  C. Caux,et al.  Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic Sites , 1998, The Journal of experimental medicine.

[69]  Timothy N. C. Wells,et al.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[70]  M. Baggiolini,et al.  The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7 , 1998, European journal of immunology.